<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hong HJ</submitter><funding>National Research Foundation of Korea</funding><pagination>932-945</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9355985</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>54(7)</volume><pubmed_abstract>Genetic variations in mitoribosomal subunits and mitochondrial transcription factors are related to type 2 diabetes. However, the role of islet mitoribosomes in the development of type 2 diabetes has not been determined. We investigated the effects of the mitoribosomal gene on β-cell function and glucose homeostasis. Mitoribosomal gene expression was analyzed in datasets from the NCBI GEO website (GSE25724, GSE76894, and GSE76895) and the European Nucleotide Archive (ERP017126), which contain the transcriptomes of type 2 diabetic and nondiabetic organ donors. We found deregulation of most mitoribosomal genes in islets from individuals with type 2 diabetes, including partial downregulation of CRIF1. The phenotypes of haploinsufficiency in a single mitoribosomal gene were examined using β-ce</pubmed_abstract><journal>Experimental &amp; molecular medicine</journal><pubmed_title>Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failure.</pubmed_title><pmcid>PMC9355985</pmcid><funding_grant_id>NRF-2020R1A2C2010964</funding_grant_id><funding_grant_id>2017R1A5A2015369</funding_grant_id><funding_grant_id>NRF-2017R1E1A1A01075126</funding_grant_id><pubmed_authors>Chang JY</pubmed_authors><pubmed_authors>Kang BE</pubmed_authors><pubmed_authors>Park JH</pubmed_authors><pubmed_authors>Moon JH</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Choi H</pubmed_authors><pubmed_authors>Kim HJ</pubmed_authors><pubmed_authors>Hong HJ</pubmed_authors><pubmed_authors>Kang YE</pubmed_authors><pubmed_authors>Shong M</pubmed_authors><pubmed_authors>Kim JT</pubmed_authors><pubmed_authors>Ryu D</pubmed_authors><pubmed_authors>Park KS</pubmed_authors><pubmed_authors>Kang SG</pubmed_authors><pubmed_authors>Ro HJ</pubmed_authors><pubmed_authors>Lee CH</pubmed_authors><pubmed_authors>Kim YK</pubmed_authors><pubmed_authors>Joung KH</pubmed_authors><pubmed_authors>Choi MJ</pubmed_authors><pubmed_authors>Lee Y</pubmed_authors><pubmed_authors>Jo Y</pubmed_authors><pubmed_authors>Jun S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failure.</name><description>Genetic variations in mitoribosomal subunits and mitochondrial transcription factors are related to type 2 diabetes. However, the role of islet mitoribosomes in the development of type 2 diabetes has not been determined. We investigated the effects of the mitoribosomal gene on β-cell function and glucose homeostasis. Mitoribosomal gene expression was analyzed in datasets from the NCBI GEO website (GSE25724, GSE76894, and GSE76895) and the European Nucleotide Archive (ERP017126), which contain the transcriptomes of type 2 diabetic and nondiabetic organ donors. We found deregulation of most mitoribosomal genes in islets from individuals with type 2 diabetes, including partial downregulation of CRIF1. The phenotypes of haploinsufficiency in a single mitoribosomal gene were examined using β-ce</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2026-05-09T15:38:41.883Z</modification><creation>2024-11-06T07:21:20.386Z</creation></dates><accession>S-EPMC9355985</accession><cross_references><pubmed>35804190</pubmed><doi>10.1038/s12276-022-00797-x</doi></cross_references></HashMap>